Adherence to Growth Hormone Treatment in Children During COVID-19 Pandemic
CONCLUSION: During the COVID-19 pandemic, the poor adherence rate was 15%, and duration of GH therapy and older age were important factors. There was a negative effect on adherence during the pandemic period.PMID:38488049 | DOI:10.4274/jcrpe.galenos.2024.2023-10-8 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Erdal Eren Semra Çetinkaya Yasemin Denkboy Ongen Ummahan Tercan Şükran Darcan Hande Turan Murat Ayd ın Fatma Yavuzy ılmaz Fatih Kilci Beray Selver Eklio ğlu Nihal Hatipo ğlu Kubra Yuksek Acinikli Zerrin Orbak Emine Çamtosun Şenay Savaş Erdeve Em Source Type: research

Long-acting Growth Hormone Therapy, Rational and Future Aspects
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2023-11-8. Online ahead of print.ABSTRACTRecombinant growth hormone (GH) is administered as daily subcutaneous injections. Daily treatment can be challenging for children/adolescents as well as for parents and/or caregivers (legal representatives, guardians of children in institutional care). Challenges associated with daily treatment may result in missing several doses and non-adherence with treatment leads to inadequate growth response. As an inadequate growth response does not meet criteria for continuing treatment, payers (commercial or public)...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Semra Çetinkaya Erdal Eren Furkan Erdo ğan Feyza Darendeliler Source Type: research

Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2024-1-15. Online ahead of print.ABSTRACTSuccessful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycaemic values, quality of life and life expectancy similar to peers, prevention of long-term complications, prevention of severe hypoglycaemia as much as possible, facilitation of glucose management, etc. International Society for Pediatric and Adolescent Diabetes (ISPAD) has been up...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Sukru Hatun Tugba Gokce Ecem Can Elif Eviz Kagan Ege Karakus Carmel Smart Ragnar Hanas Gul Yesiltepe Mutlu Source Type: research

Reversibility of Hyperglycemic States in Children with Obesity-Diagnostic Pitfalls in the Assessment of Glucose Metabolism in Children and Adolescents with Obesity
CONCLUSIONS: IFG and IGT are common in pediatric patients with obesity, while the progression to DM2 is a rare condition. Disorders of glucose metabolism disorders have reversible character. Every change of BMI Z-score has a significant impact on changes of glucose levels.PMID:38488037 | DOI:10.4274/jcrpe.galenos.2024.2023-8-9 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Anna Iwa ńska Ma łgorzata Wójcik Ewa Szczudlik Anna St ępniewska Jerzy B Starzyk Source Type: research

Adherence to Growth Hormone Treatment in Children During COVID-19 Pandemic
CONCLUSION: During the COVID-19 pandemic, the poor adherence rate was 15%, and duration of GH therapy and older age were important factors. There was a negative effect on adherence during the pandemic period.PMID:38488049 | DOI:10.4274/jcrpe.galenos.2024.2023-10-8 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Erdal Eren Semra Çetinkaya Yasemin Denkboy Ongen Ummahan Tercan Şükran Darcan Hande Turan Murat Ayd ın Fatma Yavuzy ılmaz Fatih Kilci Beray Selver Eklio ğlu Nihal Hatipo ğlu Kubra Yuksek Acinikli Zerrin Orbak Emine Çamtosun Şenay Savaş Erdeve Em Source Type: research

Long-acting Growth Hormone Therapy, Rational and Future Aspects
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2023-11-8. Online ahead of print.ABSTRACTRecombinant growth hormone (GH) is administered as daily subcutaneous injections. Daily treatment can be challenging for children/adolescents as well as for parents and/or caregivers (legal representatives, guardians of children in institutional care). Challenges associated with daily treatment may result in missing several doses and non-adherence with treatment leads to inadequate growth response. As an inadequate growth response does not meet criteria for continuing treatment, payers (commercial or public)...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Semra Çetinkaya Erdal Eren Furkan Erdo ğan Feyza Darendeliler Source Type: research

Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2024-1-15. Online ahead of print.ABSTRACTSuccessful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycaemic values, quality of life and life expectancy similar to peers, prevention of long-term complications, prevention of severe hypoglycaemia as much as possible, facilitation of glucose management, etc. International Society for Pediatric and Adolescent Diabetes (ISPAD) has been up...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Sukru Hatun Tugba Gokce Ecem Can Elif Eviz Kagan Ege Karakus Carmel Smart Ragnar Hanas Gul Yesiltepe Mutlu Source Type: research

Reversibility of Hyperglycemic States in Children with Obesity-Diagnostic Pitfalls in the Assessment of Glucose Metabolism in Children and Adolescents with Obesity
CONCLUSIONS: IFG and IGT are common in pediatric patients with obesity, while the progression to DM2 is a rare condition. Disorders of glucose metabolism disorders have reversible character. Every change of BMI Z-score has a significant impact on changes of glucose levels.PMID:38488037 | DOI:10.4274/jcrpe.galenos.2024.2023-8-9 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Anna Iwa ńska Ma łgorzata Wójcik Ewa Szczudlik Anna St ępniewska Jerzy B Starzyk Source Type: research

Adherence to Growth Hormone Treatment in Children During COVID-19 Pandemic
CONCLUSION: During the COVID-19 pandemic, the poor adherence rate was 15%, and duration of GH therapy and older age were important factors. There was a negative effect on adherence during the pandemic period.PMID:38488049 | DOI:10.4274/jcrpe.galenos.2024.2023-10-8 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Erdal Eren Semra Çetinkaya Yasemin Denkboy Ongen Ummahan Tercan Şükran Darcan Hande Turan Fatma Yavuzy ılmaz Fatih Kilci Beray Selver Eklio ğlu Nihal Hatipo ğlu Kubra Yuksek Acinikli Zerrin Orbak Emine Çamtosun Şenay Savaş Erdeve Emrullah Arslan Source Type: research

Long-acting Growth Hormone Therapy, Rational and Future Aspects
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2023-11-8. Online ahead of print.ABSTRACTRecombinant growth hormone (GH) is administered as daily subcutaneous injections. Daily treatment can be challenging for children/adolescents as well as for parents and/or caregivers (legal representatives, guardians of children in institutional care). Challenges associated with daily treatment may result in missing several doses and non-adherence with treatment leads to inadequate growth response. As an inadequate growth response does not meet criteria for continuing treatment, payers (commercial or public)...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Semra Çetinkaya Erdal Eren Furkan Erdo ğan Feyza Darendeliler Source Type: research

Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2024-1-15. Online ahead of print.ABSTRACTSuccessful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycaemic values, quality of life and life expectancy similar to peers, prevention of long-term complications, prevention of severe hypoglycaemia as much as possible, facilitation of glucose management, etc. International Society for Pediatric and Adolescent Diabetes (ISPAD) has been up...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Sukru Hatun Tugba Gokce Ecem Can Elif Eviz Kagan Ege Karakus Carmel Smart Ragnar Hanas Gul Yesiltepe Mutlu Source Type: research

Reversibility of Hyperglycemic States in Children with Obesity-Diagnostic Pitfalls in the Assessment of Glucose Metabolism in Children and Adolescents with Obesity
CONCLUSIONS: IFG and IGT are common in pediatric patients with obesity, while the progression to DM2 is a rare condition. Disorders of glucose metabolism disorders have reversible character. Every change of BMI Z-score has a significant impact on changes of glucose levels.PMID:38488037 | DOI:10.4274/jcrpe.galenos.2024.2023-8-9 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Anna Iwa ńska Ma łgorzata Wójcik Ewa Szczudlik Anna St ępniewska Jerzy B Starzyk Source Type: research

Adherence to Growth Hormone Treatment in Children During COVID-19 Pandemic
CONCLUSION: During the COVID-19 pandemic, the poor adherence rate was 15%, and duration of GH therapy and older age were important factors. There was a negative effect on adherence during the pandemic period.PMID:38488049 | DOI:10.4274/jcrpe.galenos.2024.2023-10-8 (Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology)
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Erdal Eren Semra Çetinkaya Yasemin Denkboy Ongen Ummahan Tercan Şükran Darcan Hande Turan Fatma Yavuzy ılmaz Fatih Kilci Beray Selver Eklio ğlu Nihal Hatipo ğlu Kubra Yuksek Acinikli Zerrin Orbak Emine Çamtosun Şenay Savaş Erdeve Emrullah Arslan Source Type: research

Long-acting Growth Hormone Therapy, Rational and Future Aspects
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2023-11-8. Online ahead of print.ABSTRACTRecombinant growth hormone (GH) is administered as daily subcutaneous injections. Daily treatment can be challenging for children/adolescents as well as for parents and/or caregivers (legal representatives, guardians of children in institutional care). Challenges associated with daily treatment may result in missing several doses and non-adherence with treatment leads to inadequate growth response. As an inadequate growth response does not meet criteria for continuing treatment, payers (commercial or public)...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Semra Çetinkaya Erdal Eren Furkan Erdo ğan Feyza Darendeliler Source Type: research

Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations
J Clin Res Pediatr Endocrinol. 2024 Mar 15. doi: 10.4274/jcrpe.galenos.2024.2024-1-15. Online ahead of print.ABSTRACTSuccessful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycaemic values, quality of life and life expectancy similar to peers, prevention of long-term complications, prevention of severe hypoglycaemia as much as possible, facilitation of glucose management, etc. International Society for Pediatric and Adolescent Diabetes (ISPAD) has been up...
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - March 15, 2024 Category: Endocrinology Authors: Sukru Hatun Tugba Gokce Ecem Can Elif Eviz Kagan Ege Karakus Carmel Smart Ragnar Hanas Gul Yesiltepe Mutlu Source Type: research